On The Fly
|
Check out this evening's… ShowHide Related Items >><< - $43.90 /
-0.3449 (-0.78%) - 16:09 Today
- Western Digital falls 7% to $41.00 per share after Q2 earnings miss and guidance
- 16:06 Today
- Western Digital enters $900M convertible preferred equity investment by Apollo
- 10/26/22
- Kioxia, Western Digital open semiconductor fabrication facility Fab7 in Japan
- 08/31/22
- Western Digital, Micron lower in pre-market after Seagate guidance cut
TSHA Taysha Gene Therapies - 16:09 Today
- Taysha Gene Therapies provides update on TSHA-120 program in GAN
- 12/16/22
- Taysha Gene Therapies names Sean Nolan CEO
- 10/24/22
- Astellas to buy 15% of Taysha Gene Therapies for $50M, obtain TSHA-102 license
- 08/11/22
- Taysha Gene Therapies expects cash to fund expenses into 4Q23
- $253.76 /
+4.245 (+1.70%) - 12/07/22
- Stryker raises quarterly dividend 7.9% to 7.5c per share
- 10/31/22
- Stryker expects adverse EPS, revenue impact from foreign exchange rates
- 09/20/22
- Stryker receives FDA 510(k) clearance for OptaBlate bone tumor ablation system
- 16:56 Today
- Snap expects to see full benefit of cost reductions in Q1
- 16:48 Today
- Snap sees Q1 DAU 382M-384M, expects adjusted EBITDA breakeven in Q1
- 16:46 Today
- Snap says the quarter 'materialized largely as expected'
- 16:44 Today
- Snap says 'remains focused' on accelerating revenue growth.
SMCI Super Micro Computer - 16:33 Today
- Super Micro Computer falls 11% to $64.66 after Q2 results and guidance
- 16:30 Today
- Super Micro Computer reports Q2 gross margin 18.8% vs. 14.0% y/y
- 01/10/23
- Spruce Point issues 'Strong Sell' opinion on Super Micro Computer
- 12/22/22
- Super Micro Computer to replace Steel Dynamics in S&P 400 at open on 12/22
PSTX Poseida Therapeutics - 18:28 Today
- Poseida Therapeutics founder and executive chairman Eric Ostertag to retire
- 12/11/22
- Poseida presents preclinical data from P-FVIII-101 gene therapy for hemophilia A
- 10/05/22
- Poseida Therapeutics to present trial in progress poster for Phase 1 study
- 08/11/22
- Poseida Therapeutics expects cash to fund operations into at least mid-2024
- 01/26/23
- O-I Glass offers first look at MAGMA operations
- 01/04/23
- FTC announces actions against several companies over noncompete restrictions
- 08/29/22
- Axalta Coating appoints Bertsch to board of directors
- 08/29/22
- Axalta Coating appoints Jan Bertsch to board of directors
- 01/26/23
- Match Group names executive leadership team
- 12/13/22
- Match Group up 8% after Bloomberg report on Apple App store plans
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 09/29/22
- Match Group names Linda Kim as COO of Hyperconnect
- 01/23/23
- Enthusiast Gaming announces partnership with Mondelez's SOUR PATCH KIDS
- 01/19/23
- Mondelez releases fourth annual State of Snacking report
- 01/09/23
- Mondelez to release special edition Oreos with Xbox images
- 12/19/22
- Mondelez to sell developed-market gum business to Perfetti Van Melle for $1.35B
- 18:06 Today
- Jasper Therapeutics discloses Carlyle Group buys $4.7M in common stock
- 01/25/23
- Jasper Therapeutics announces pricing of $90M public offering
- 01/13/23
- Jasper Therapeutics to present data for briquilimab at 2023 Tandem Meetings
- 01/10/23
- Jasper Therapeutics announces development prioritization of briquilimab
- 16:19 Today
- Juniper CFO says aiming to expand 2023 operating margin by at least 100bps
- 12/12/22
- Juniper selected as preferred technology partner for Deutsche Telekom's SD-X
- 12/07/22
- Juniper CEO sells $604K in common stock
- 10/28/22
- Juniper director Kriens sells 140,000 common shares
- 11/14/22
- Houlihan Lokey has agreed to acquire independent advisory firm Oakley Advisory
- 11/09/22
- Houlihan Lokey CEO Beiser sells $1.5M in company shares
- 16:22 Today
- Hawaiian Holdings sees FY23 ASMs up 9.5%-12.5%
- 16:21 Today
- Hawaiian Holdings sees Q1 ASMs up 14%-17%
- 10/21/22
- Hawaiian Holdings announces agreement with Amazon.com
- 12/08/22
- Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds
- 11/01/22
- Edwards Lifesciences authorizes $750M accelerated share repurchase
- 10/28/22
- Edwards Lifesciences falls -16.6%
- 10/28/22
- Edwards Lifesciences falls -14.3%
- 17:17 Today
- Chairman of Electronic Arts Wilson sells 5,000 shares of company stock
- 17:17 Today
- Electronic Arts sees mid-single digit growth in net bookings in 2024
- 17:15 Today
- Electronic Arts says taking more measured approach to Q4 game launches
- 17:07 Today
- EA says 'FIFA Mobile' engagement up triple digits in Q3
- $463.21 /
+10.05 (+2.22%) - 01/04/23
- Auto Lender Credit Acceptance Corp sued by NY AG Letitia James and CFPB
- 10/31/22
- Credit Acceptance says Ravi Mohan joins as CTO
- 10/31/22
- Ashland announces FDA accepted injectable excipient into novel pilot program
- 10/17/22
- Ashland launches 2021 ESG report
- 09/21/22
- Ashland increases prices up to 15% due to inflation-related costs
- 08/30/22
- Ashland announces expansion of Viatel manufacturing in Ireland
- 01/20/23
- AMD identified as respondent in ITC investigation of certain integrated circuits
- 01/19/23
- AMD adaptive computing tech enables DENSO LiDAR system
- 01/11/23
- AMD CFO Devinder Kumar to retire, Jean Hu appointed new CFO
- 12/20/22
- EU opens antitrust probe into Broadcom's proposed $61B VMware bid
- $463.21 /
+10.05 (+2.22%) - 11/03/22 BMO Capital
- Credit Acceptance price target lowered to $364 from $477 at BMO Capital
- 11/02/22 Credit Suisse
- Credit Acceptance price target lowered to $410 from $430 at Credit Suisse
- 08/02/22 Credit Suisse
- Credit Acceptance price target lowered to $440 from $460 at Credit Suisse
- 05/03/22 Credit Suisse
- Credit Acceptance price target raised to $460 from $440 at Credit Suisse
- 01/09/23 Wells Fargo
- O-I Glass upgraded to Overweight from Equal Weight at Wells Fargo
- 01/04/23 Citi
- O-I Glass upgraded to Buy from Neutral at Citi
- 11/14/22 Barclays
- O-I Glass price target raised to $13 from $12 at Barclays
- 10/13/22 BofA
- O-I Glass price target lowered to $17 from $18 at BofA
- $253.76 /
+4.245 (+1.70%) - 01/25/23 KeyBanc
- Stryker initiated with a Sector Weight at KeyBanc
- 01/09/23 RBC Capital
- Stryker upgraded to Outperform from Sector Perform at RBC Capital
- 01/04/23 Barclays
- Stryker price target raised to $265 from $257 at Barclays
- 01/03/23 Evercore ISI
- Stryker price target raised to $265, added to 'TAP Outperform' list at Evercore
- 07:37 Today Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/30/23 Piper Sandler
- Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler
- 12/12/22 Canaccord
- Edwards Lifesciences price target lowered to $73 from $78 at Canaccord
- 12/12/22 Citi
- Edwards Lifesciences price target lowered to $92 from $99 at Citi
- 01/30/23 Morgan Stanley
- Intel's quarter points to some risk for AMD in Q1, says Morgan Stanley
- 01/30/23 Susquehanna
- AMD price target raised to $88 from $80 at Susquehanna
- 01/27/23 BofA
- Intel price target lowered to $25 from $28 at BofA
- 01/27/23 Barclays
- Intel price target lowered to $27 from $30 at Barclays
- 01/06/23 Mizuho
- Mondelez price target raised to $78 from $75 at Mizuho
- 01/03/23 Wells Fargo
- Mondelez initiated with an Overweight at Wells Fargo
- 01/03/23 RBC Capital
- Mondelez downgraded to Sector Perform from Outperform at RBC Capital
- 12/20/22 Morgan Stanley
- Mondelez price target raised to $75 from $69 at Morgan Stanley
- 11/14/22 Oppenheimer
- Jasper Therapeutics price target lowered to $8 from $21 at Oppenheimer
- 10/31/22 EF Hutton
- Jasper Therapeutics initiated with a Buy at EF Hutton
- 02/28/22 Cantor Fitzgerald
- Jasper Therapeutics initiated with an Overweight at Cantor Fitzgerald
- 02/28/22 Cantor Fitzgerald
- Jasper Therapeutics initiated with an Overweight at Cantor Fitzgerald
- 01/20/23 MKM Partners
- MKM Partners cuts Pinterest to Neutral, sees balanced risk-reward
- 01/19/23 JPMorgan
- JPMorgan calls out Meta as top pick ahead of earnings from online ads group
- 01/18/23 OTR Global
- Snap downgraded to Mixed from Positive view at OTR Global
- 01/17/23 JMP Securities
- Snap downgraded to Market Perform from Outperform at JMP Securities
- 12/20/22 Deutsche Bank
- Hawaiian Holdings price target lowered to $13 from $17 at Deutsche Bank
- 12/16/22 Goldman Sachs
- Hawaiian Holdings resumed with a Sell at Goldman Sachs
- 10/06/22 BofA
- Hawaiian Holdings price target lowered to $10 from $12 at BofA
- 08/15/22 Melius Research
- Hawaiian Holdings initiated with a Hold at Melius Research
- 01/27/23 Wedbush
- Electronic Arts initiated with an Outperform at Wedbush
- 01/27/23 Credit Suisse
- Electronic Arts price target raised to $154 from $143 at Credit Suisse
- 01/25/23 Barclays
- Electronic Arts price target raised to $132 from $130 at Barclays
- 01/17/23 Benchmark
- Electronic Arts price target lowered to $150 from $188 at Benchmark
- 17:59 Today Piper Sandler
- Match Group turnaround bumpier than hoped, says Piper Sandler
- 01/30/23 Deutsche Bank
- Match Group price target raised to $65 from $60 at Deutsche Bank
- 01/26/23 Citi
- Match Group initiated with a Neutral at Citi
- 01/25/23 Barclays
- Match Group price target raised to $52 from $50 at Barclays
- $43.90 /
-0.3449 (-0.78%) - 01/23/23 Exane BNP Paribas
- Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas
- 01/06/23 Benchmark
- Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report
- 01/06/23 Benchmark
- Western Digital upgraded to Hold from Sell at Benchmark
- 01/05/23 Deutsche Bank
- Western Digital, Kioxia deal makes 'a lot of sense,' says Deutsche Bank
- 10/12/22 Jefferies
- Varex Imaging initiated with a Hold at Jefferies
- 01/17/23 Piper Sandler
- Juniper price target raised to $32 from $31 at Piper Sandler
- 12/20/22 JPMorgan
- JPMorgan ups Juniper target, adds to Analyst Focus List
- 12/13/22 Morgan Stanley
- Juniper price target raised to $29 from $25 at Morgan Stanley
- 10/26/22 Piper Sandler
- Juniper price target raised to $31 from $29 at Piper Sandler
SMCI Super Micro Computer - 01/11/23 Northland
- Super Micro short report presents attractive entry point, says Northland
- 12/29/22 Northland
- Super Micro Computer named a top pick entering 2023 at Northland
- 11/02/22 Northland
- Super Micro Computer price target raised to $165 from $137 at Northland
- 11/02/22 Wedbush
- Super Micro Computer price target raised to $65 from $55 at Wedbush
- 01/26/23 BMO Capital
- Ashland price target lowered to $135 from $139 at BMO Capital
- 01/26/23 Mizuho
- Ashland price target lowered to $136 from $141 at Mizuho
- 11/09/22 Deutsche Bank
- Ashland price target raised to $125 from $120 at Deutsche Bank
- 11/09/22 Wells Fargo
- Ashland price target raised to $118 from $104 at Wells Fargo
- 01/02/23 Keefe Bruyette
- Houlihan Lokey price target raised to $95 from $90 at Keefe Bruyette
- 07/18/22 Morgan Stanley
- Houlihan Lokey upgraded to Equal Weight from Underweight at Morgan Stanley
- 07/08/22 Piper Sandler
- Houlihan Lokey price target lowered to $78 from $80 at Piper Sandler
- 04/07/22 Piper Sandler
- Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
TSHA Taysha Gene Therapies - 01/27/23 Morgan Stanley
- Taysha Gene Therapies downgraded at Morgan Stanley on management uncertainty
- 01/27/23 Morgan Stanley
- Taysha Gene downgraded to Equal Weight from Overweight at Morgan Stanley
- 01/19/23 JMP Securities
- Taysha Gene Therapies price target lowered to $6 from $20 at JMP Securities
- 11/14/22 Wells Fargo
- Taysha Gene Therapies price target lowered to $14 from $20 at Wells Fargo
PSTX Poseida Therapeutics - 01/04/23 H.C. Wainwright
- Poseida Therapeutics initiated with a Buy at H.C. Wainwright
- 12/28/22 Cantor Fitzgerald
- Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
- 11/11/22 BTIG
- Poseida Therapeutics price target lowered to $14 from $20 at BTIG
- 08/09/22 Piper Sandler
- Poseida Therapeutics price target raised to $11 from $9 at Piper Sandler
- $43.90 /
-0.3449 (-0.78%) - 16:08 Today
- Western Digital sees Q3 EPS ($1.70) to ($1.40), consensus (30c)
- 16:07 Today
- Western Digital reports Q2 EPS (42c), consensus (12c)
- 10/27/22
- Western Digital sees Q2 EPS (25c)-5c, consensus 34c
- 16:08 Today
- Varex sees Q2 adjusted EPS 5c-25c, consensus 31c
- 16:08 Today
- Varex reports Q1 adjusted EPS 21c, consensus 20c
- 11/15/22
- Varex Imaging sees Q1 adjusted EPS 10c-30c, one estimate 23c
- 11/15/22
- Varex Imaging reports Q4 adjusted EPS 42c, consensus 36c
TSHA Taysha Gene Therapies - 11/08/22
- Taysha Gene Therapies reports Q3 EPS (64c), consensus (82c)
- 08/11/22
- Taysha Gene Therapies reports Q2 EPS (84c) vs. ($1.09) last year
- $253.76 /
+4.245 (+1.70%) - 16:08 Today
- Stryker sees FY23 adjusted EPS $9.85-$10.15, consensus $9.86
- 16:07 Today
- Stryker reports Q4 adjusted EPS $3.00, consensus $2.84
- 10/31/22
- Stryker reports Q3 adjusted EPS $2.12, consensus $2.23
- 10/31/22
- Notable companies reporting after market close
- 17:10 Today
- Snap sees Q1 revenue down 2%-10% y/y, consensus $1.08B
- 16:10 Today
- Snap reports Q4 EPS 14c, consensus 11c
- 10/20/22
- Snap reports Q3 adjusted EPS 8c, consensus (1c)
SMCI Super Micro Computer - 16:29 Today
- Super Micro Computer backs FY23 EPS view of $9.00-$11.30, consensus $10.49
- 16:28 Today
- Super Micro Computer sees Q3 EPS $1.88-$2.14, consensus $2.12
- 16:27 Today
- Super Micro Computer reports Q2 EPS $3.26, consensus $3.03
- 01/18/23
- Super Micro Computer raises Q2 adjusted EPS view to $3.07-$3.22, consensus $2.73
PSTX Poseida Therapeutics - 11/10/22
- Poseida Therapeutics reports Q3 EPS 92c, consensus (65c)
- 08/11/22
- Poseida Therapeutics reports Q2 EPS (69c) vs (74c) last year
- 16:27 Today
- O-I Glass sees FY23 EPS greater than $2.50, consensus $2.28
- 16:25 Today
- O-I Glass sees Q1 EPS 80c-85c, consensus 53c
- 16:23 Today
- O-I Glass reports Q4 EPS 38c, consensus 32c
- 11/01/22
- O-I Glass sees FY22 EPS at high end of guidance $2.20 $2.25, consensus $2.19
- 16:15 Today
- Match Group sees FY23 revenue up 5%-10% y/y, consensus $3.44B
- 16:14 Today
- Match Group sees Q1 revenue $790M-$800M, consensus $817.34M
- 16:13 Today
- Match Group reports Q4 EPS 30c, consensus 46c
- 16:13 Today
- Mondelez sees FY23 adjusted EPS growth high-single digits, consensus $3.11
- 16:12 Today
- Mondelez reports Q4 adjusted EPS 71c, consensus 70c
- 11/01/22
- Mondelez raises FY22 adjusted EPS view to 10% from up mid-to-high single digits
- 11/10/22
- Jasper Therapeutics reports Q3 EPS (32c), consensus (34c)
- 08/12/22
- Jasper Therapeutics reports Q2 EPS (29c), consensus (31c)
- 16:22 Today
- Juniper raises quarterly dividend to 22c from 21c per share
- 16:21 Today
- Juniper sees Q1 EPS 37c-47c, consensus 40c
- 16:18 Today
- Juniper reports preliminary Q4 EPS 65c, consensus 65c
- 16:17 Today
- Houlihan Lokey reports Q3 adjusted EPS $1.14, consensus $1.15
- 10/27/22
- Houlihan Lokey reports Q2 adjusted EPS $1.19, consensus $1.03
- 16:04 Today
- Hawaiian Holdings reports Q4 adjusted EPS (49c), consensus (70c)
- 10/25/22
- Hawaiian Holdings sees Q4 adjusted EBITDA ($5M)-$35M
- 10/25/22
- Hawaiian Holdings reports Q3 EPS (15c), consensus (18c)
- 16:17 Today
- Edwards Lifesciences sees Q1 adjusted EPS 58c-64c, consensus 59c
- 16:16 Today
- Edwards Lifesciences backs FY23 adjusted EPS $2.45-$2.60, consensus $2.50
- 16:15 Today
- Edwards Lifesciences reports Q4 adjusted EPS 64c, consensus 61c
- 13:20 Today
- Notable companies reporting after market close
- 17:22 Today
- EA sees mid-single digit top and bottom line growth in FY24
- 16:04 Today
- Electronic Arts cuts FY23 EPS view to $2.97-$3.11 from $3.11-$3.34
- 16:03 Today
- Electronic Arts sees Q4 EPS 5c-20c, consensus $2.22
- 16:02 Today
- Electronic Arts reports Q3 EPS 73, consensus $3.05
- $463.21 /
+10.05 (+2.22%) - 16:05 Today
- Credit Acceptance reports Q4 EPS $11.74, consensus $7.16
- 11/01/22
- Credit Acceptance reports Q3 EPS $13.36 consensus $10.32
- 17:04 Today
- Ashland reaffirms FY23 revenue view $2.5B-$2.7B, consensus $2.53B
- 17:03 Today
- Ashland reports Q1 adjusted EPS 97c, consensus 99c
- 01/25/23
- Ashland reaffirms FY23 revenue view $2.5B-$2.7B, consensus $2.53
- 01/25/23
- Ashland sees Q1 adjusted EPS 97c, consensus $1.1
- 16:19 Today
- AMD sees Q1 revenue $5.3B +/- $300M, consensus $5.48B
- 16:18 Today
- AMD reports Q4 EPS 69c, consensus 67c
- 11/01/22
- AMD cuts FY22 revenue view to $23.5B +/- $300M from $26.3B +/- $300M
|